SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

CytomX Therapeutics, Inc. (CTMX)

CTMX RSS Feed
Add CTMX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/5/2017 10:10:17 AM - Followers: 3 - Board type: Free - Posts Today: 0

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and The University of Texas M. D. Anderson Cancer Center to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTMX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CTMX News: Initial Statement of Beneficial Ownership (3) 05/18/2017 07:29:11 PM
CTMX News: CytomX Announces Upcoming Poster Presentation at American Society for Clinical Oncology Annual Meeting 05/17/2017 08:00:00 AM
CTMX News: Statement of Changes in Beneficial Ownership (4) 05/16/2017 04:59:00 PM
CTMX News: Current Report Filing (8-k) 05/15/2017 05:00:47 PM
CTMX News: CytomX Announces Management Team Changes 05/15/2017 04:01:00 PM